Global cannabis regulation is increasing

Regulations on the medicinal use of the cannabis plant around the world are increasing, and although Europe is a little late in this regard, effective and personalized regulation will arrive sooner rather than later. The European Medicines Agency has asked European Union countries for scientific information on the medical use of cannabis, including the use of buds from marijuana plants.

O European Medicines Agency calls on the scientific community to provide data confirming the interest and the important role that the cannabis plant is acquiring for medicinal treatments, including the bud, which is presumed to have great potential, according to Carola Pérez, President of the Spanish Observatory of Medicinal Cannabishe. In this sense, the procedures for the elaboration of a monographic guide on medical cannabis for the countries of the European Union.

steps being taken

The agency requested that all available data on the therapeutic applications, safety and efficacy offered by the cannabis plant be collected. O The EMA (European Medicines Agency) proposed to all interested parties from the member states of the European Union to send scientific data on the medicinal properties of cannabisboth from plant preparations and in the raw form of shoots.

At the end of January, the said agency published a document explaining the usefulness of the guidelines and the procedure for their development. In this way, it asks health professionals, scientific societies, industry, as well as patients and their associations to send relevant and detailed information so that it can be taken into account.

If Europe finally regulates medical cannabis broadly and objectively, many patients could take advantage of purchasing cheap seeds It is make automatic crops to treat your ailments or diseases without fear. Being an increasingly numerous group of stakeholders for this regulation to move forward.

Legalization helps research

Germany is one of the most advanced European countries in terms of the market for hemp products for therapeutic purposes. However, no really relevant research on the subject has been carried out by the public sector, according to Franjo Grotenhermen, Executive Director of the International Association for Cannabinoid Medicines (AIMC).

However, already in 2017, Germany legalized the medicinal use of cannabis and medicines based on this plant, thus facilitating their access for therapeutic purposes. Data indicate that prior to the modification of German legislation, medical cannabis was only prescribed to around 1,000 patients. After the law was passed in 2018, the number rose to 142,000 medical marijuana prescriptions..

Read Also:  Sehwag picked Team India's starting XI for the T20 World Cup and expressed his opinion about this player in place of Hardik

With this patient data, it is much moreIt is easier to carry out studies and complete monitoring of your evolution to be able to draw statistics and draw conclusions about its benefits.

Subsequently, other European countries followed Germany, such as the Czech Republic, Italy and Malta, which facilitated patient access to medical cannabis by introducing changes in legislation.

According to Grotenhermen, when marijuana and its derivatives are prescribed by a doctor, bureaucratic barriers to carrying out investigations are reduced, since they are already considered medicines. In his words “It is much more expensive to do research with narcotics when their clinical use is not allowed, that is, they are not drugs”.

Professionals are still biased

However, what is happening in Germany has not been the general trend followed by the other member states, where prejudices on the part of many professionals continue. Medical cannabis prescription only accelerates its pace in Germany, while in other countries they only slow these changes.

The key is legalization. For Grotenhermen, research associate at nova-Institut GmbH in Hürth, in the renewable raw materials department, where he deals with hemp as a medicine, all countries that have legalized the medical use of cannabis, such as Canada, Holland and Israel, saw how health professionals have accepted your prescription for medical purposes. “There are always the pioneers who have an open mind. Then come the doctors who are approached by their patients and, over time, convinced to give it a try. Widespread acceptance takes time.”

Although there is still a long way to go, this request by the European Medicines Agency to European Union countries for scientific information on the medicinal use of cannabis, including the use of buds, is likely to accelerate steps towards its standardization.

Recent Articles

Related News

Leave A Reply

Please enter your comment!
Please enter your name here